Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Mostly just gets awareness out about the drug and show there is an outcry of support for this drug. There’s only a small handful of hospitals that have access to it even though it’s been approved for compassionate care use.
Yes, the website automatically sets mini goals that adjust higher, but it’s not limited on how many it can get.
840 signatures on the petition and counting.
http://chng.it/KCwLbKYF
NeroRX, massive contract with GEM?
https://www.gemny.com/
[url=https://ibb.co/gPBzNny][/url]
Nothing like a semi global internet outage to stir things up.
Closing in on 300 signatures.
I’m actually kinda surprised on the momentum we have so far.
http://chng.it/KCwLbKYF
A nurse on YouTube was doing updates on COVID and she knows people inside of Houston
Thank you for signing and chipping in! And thank you everyone else! Closing in on 200 signatures fast.
Much appreciated! Let’s get the word out!
Awesome! Thank you!
Started a petition!
http://chng.it/tg47vdqq8P
New Idea for getting Aviptadil exposure.
Someone start a change.org petition to get aviptadil EUA or approval and we can spread the petition across social media and investor forums. We have enough members here and on twitter to get some momentum.
This could be interesting. If the WH knows about this, but the left breaks the story before the right, it could become an election decider. First to break the story will be first to win the people’s admiration.
Imagine after HCQ, and The plasma flops, the lefts come out swinging with aviptadil as their front runner drug of choice.
Keep up the good work!
Chris Cuomo contact info
http://chriscuomo.com/ask-chris/
This weekends theme song.
Andrew Cuomo contact page!
https://www.governor.ny.gov/content/governor-contact-form
Finally got around to sending him a message. I encourage everyone else to do so! If there is a governor that will take the scientific route and avoid politicizing this drug, his is our guy to get the world out. Added bonus. Chris Cuomo his brother, is a prime time reporter for CNN.
@Fred
I’m starting to ponder the realm of intentional dilution to keep the average PPS down while all warrants were exercised for tax reasons. If all warrants have been truly exercised, I wonder if that removed the need for continued price draw down. Big news might be expected near term. The volatility has all but consolidated into a tight Channel now. Sooo...
idk I’ve tried to predict this all along and it never follows any logical pattern. I’m just fishing for ideas and idle conversation now. It could tank and GEM dumps a billion shares, runs us to the trips and we all lose the farm and our lunch money by lunch Monday. Who knows. It’s OTC.
Just a fair disclosure, those 2 posts are written by somebody else, I was just sharing them. I wish I could take credit for either or but alas, I’m a busy man.
VIP in cancer treatment
Disclaimer. I stole this DD from another board.
Translated from German.
The treatment of cancer patients can no longer be imagined without new types of immunotherapies. However, they also repeatedly lead to life-threatening inflammation of the lungs. Scientists and doctors at the Freiburg University Medical Center have now successfully used a novel therapeutic approach on a patient. The patient had received immunotherapy for melanoma, also known as black skin cancer. However, this triggered severe pneumonia. The doctors decided to give him the intestinal hormone "vasoactive intestinal peptide" (VIP) for inhalation, the use of which is being researched at the Freiburg University Medical Center for similar diseases. The pneumonia completely disappeared within a few weeks, something that had not previously been possible with cortisone. The case report was published in the prestigious New England Journal of Medicine on June 25, 2020.
"After the patient initially received cortisone, the shortness of breath and coughing quickly returned," reports Dr. Frank Meiß, Senior Consultant in Charge at the Clinic for Dermatology and Venereology at the Freiburg University Medical Center. Therefore, it was decided together with the patient to go a new way and give him VIP for inhalation.
The Freiburg doctors and scientists came up with the idea of the VIP gift because they were researching new therapeutic approaches for the lung disease sarcoid in several research projects and had already achieved initial successes with VIP. "We chose this experimental therapy because there are similarities between sarcoid and this type of non-bacterial pneumonia," says Dr. Björn Christian Frye, senior physician at the Pneumology Clinic at the University Hospital Freiburg.
“We had expected an improvement in the pneumonia, but were very positively surprised by the success of the therapy. The inflammation subsided and the patient's shortness of breath disappeared, ”says Prof. Dr. Joachim Müller-Quernheim, Medical Director of the Pneumology Clinic at the Freiburg University Medical Center. Such non-bacterial pneumonitis, known as pneumonitis, occurs in 10 to 20 percent of all patients with immune cancer therapy and has so far usually been treated with steroids such as cortisone. However, some of these have severe side effects and the immunotherapy must be discontinued. Instead of cortisone tablets, which only led to short-term improvement but also to side effects, the patient only had to inhale three times a day. There were no side effects under VIP therapy.
https://www.uniklinik-freiburg.de/presse/pressemitteilungen/detailansicht/2058-hormon-inhalation-stoppt-schwere-nebenwirkung-von-immun-krebstherapie.html
Updated insight from another board. Apparently I missed half the post so here is the full thing.
DD_Police here to share some real DD on RLFTF and correct some of the misinformation posted here:
1. 695m warrants were exercised today and Relief will receive just under $7.2m. Warrants were issued many years ago, e.g. GEM got 600m warrants over 3 years ago, and they are exercising the remaining warrants today, as are Relief employees. Please read financial statements and prior Relief PR’s.
2. In an interview Raj explicitly stated that they have about 700m of warrants outstanding. Today all got exercised.
3. Reasons to exercise warrants:
a. You think the price will crash and want to cash out. Highly unlikely, because GEM already has 600 million shares and they would dump those first. Unless you believe they want to dump 1.1b shares ASAP (spoiler alert: not going to happen).
b. You expect the share price to increase significantly. You will pay a lot less in taxes before spike.
c. Very suspicious that all 700m warrants got exercised. IMO Relief is not going to sell to a big pharma, as it makes no sense. Would you sell a goose that lays golden eggs, before you found out how many eggs a day it can lay? No! What makes the most sense is that Relief and NeuroRX merge, and get uplisted to NASDAQ. Relief has 3b shares outstanding now and they can give NeuroRX say 1bn shares for a total of 4b shares to create a new powerhouse pharmaceutical company. No need to even raise capital, as they can get prepaid for Samivir orders right after FDA Approval. Clearing out the warrants makes sense prior to merging.
d. To fund the inhaler study (~$15m needed). Likely a tiny piece of the puzzle.
4. In Switzerland you have a 1% wealth tax, so you may see management sell a few million shares to pay their taxes. This is what Yves Sagot did when he sold 1% of his 170+m share stake a month ago. No need to panic if it happens.
5. Dr. Javitt said in a video on 8/7/20 that 70 patients have been enrolled. 5 days later in Dr. Yo interview it was up to 85/86. That is 3 patients per day. 102nd patient enrolled about 10-14 days ago. Primary end point is at 1 week time frame. Only question I have, that no one seems to have the answer to, is do they wait for secondary end point, i.e. 28 days, before looking at data? I would hope not. The committee still needs a couple of weeks to analyze the data properly. So we are 1-30 days away.
6. RLF-100 does not reduce mortality by 90%. Please stop posting this nonsense. You are assuming that all 100% of the 21 patients would have died without rlf-100, which is unlikely speculation.
7. I keep hearing that FF Searcy was given 2 days to live prior to RLF-100. I may have missed it, but I did not ever hear/read anything of sorts. I doubt a doctor would say that.
8. RLF-100 is safe! Dr. Javitt explicitly stated that they got in writing from the FDA that the product is safe. All they have to do is prove efficacy, which is what the blinded control study is designed to do.
9. The committee looked at first 30 patients enrolled and determined that RLF-100 is safe. 9 out of 21 patients had rapid recovery from respiratory failure. Sounds like they will not wait 28 days after 102nd patient got enrolled. Maybe even look at data as soon as 102nd patient got enrolled. Say they had 10 patients on RLF-100 and 11 on placebo in initial dataset, and 8 or 9 of those dramatic recoveries were on RLF-100, then a 70-patient dataset may be enough to get an EUA. If you see 30 out of 35 with dramatic improvements, and only 5 out of 35 on placebo with similar results, that will be statistically significant. As product is “SAFE”, an EUA would be a must. If data is overwhelmingly positive then Full FDA Approval would be warranted as well. E.g. 0/35 patients died vs. 10/35 on placebo.
I have a lot more information to share, including posts on valuation as well as additional DD on RLFTF. I have been in the stock since $0.04. I have done my DD on the company and I am extremely pleased with the risk/reward. Please correct me if any of my statements are incorrect. I am interested in real DD; good or bad, and not fake information.
VIP has potential to be a game changing medical breakthrough. It has not been “extensively studied over the past 50 years”. Yes, it had several studies on small populations, that were enough to prove safety. But from an efficacy standpoint, it has been studied very little. The potential applications of this peptide are enormous and may disrupt the entire pharma industry for pulmonary applications. Make no mistake, big pharma will fight hard to suppress it. But I would have expected the STAT News and Andrew Left Citron’s of the world to be attacking it by now (not unlike CYDY). This gives me hope that the people in power have decided that RLF-100 is going to be our silver bullet to fight Covid-19. It is better than any other drug out there for multiple reasons, but the main ones are safety and MOA.
"This is the most exciting thing I've ever had the privilege of being involved in."
Wouldn’t lose a wink of sleep on this one. If your that worried you have 2 options. Cash our the chips monday morning. Or have faith in the process and just go for a walk and not worry about share price. Just some loose ends getting taken care of on the back end before the next big move.
Some insight from another board.
1. 695m warrants were exercised today and Relief will receive just under $7.2m. Warrants were issued many years ago, e.g. GEM got 600m warrants over 3 years ago, and they are exercising the remaining warrants today, as are Relief employees. Please read financial statements and prior Relief PR’s.
2. In an interview Raj explicitly stated that they have about 700m of warrants outstanding. Today all got exercised.
3. Reasons to exercise warrants: a. You think the price will crash and want to cash out. Highly unlikely, because GEM already has 600 million shares and they would dump those first. Unless you believe they want to dump 1.1b shares ASAP (spoiler alert: not going to happen). b. You expect the share price to increase significantly. You will pay a lot less in taxes before spike. c. Very suspicious that all 700m warrants got exercised. IMO Relief is not going to sell to a big pharma, as it makes no sense. Would you sell a goose that lays golden eggs, before you found out how many eggs a day it can lay? No! What makes the most sense is that Relief and NeuroRX merge, and get uplisted to NASDAQ. Relief has 3b shares outstanding now and they can give NeuroRX say 1bn shares for a total of 4b shares to create a new powerhouse pharmaceutical company. No need to even raise capital, as they can get prepaid for Samivir orders right after FDA Approval. Clearing out the warrants makes sense prior to merging. d. To fund the inhaler study (~$15m needed). Likely a tiny piece of the puzzle.
Relief Therapeutics - eine COVID-19 Hoffnung? | wallstreet-online.de - Vollständige Diskussion unter:
https://www.wallstreet-online.de/diskussion/1321697-2631-2640/relief-therapeutics-covid-19-hoffnung
It falls under the Netflix adaptation.
Wait til the toilet paper and hand sanitizer hoarders hear about this stock once we get approval . It will be FOMO buying for the record books.
Could drop, could run. Who knows. Imo these nickel deviations won’t be relevant in a few weeks. It’s all a matter of do you want to gamble being able to buy a few extra hundred shares anticipating no news?
Added more this week also. Still have my reservations about this one. But, the low float, low market cap, high insider holdings, low institutional holding is mouth watering. This could really flip either way. Lots of downside. But, tremendous upside with how few shares are kicking around on the market right now. Nice little spark and this thing could quickly run from 200m mkt cap to 1b mkt cap. And I would happily take chances on a potential bagger. Then again other Covid plays I’m in are hitting 1.2-1.7b mkt cap on volatility so the upside on this is, amazing. Wish I got in a few weeks earlier, but so goes life. Just wish admins would have approved my mod request so I could fix up that banner up top.
The final chapter?
You have sent me on a scavenger hunt of DD with your number of 50.3 each new rabbit hole draws a blank for me. My next rabbit hole of DD to chase is aztreonam in its effects on antimicrobial resistant infections such as P. aeruginosa. Here’s a quote from one article, “Low antimicrobial resistance levels were found, being the highest to aztreonam (50.3%)“
Since all signs of your DD is pointing towards inhaled version of VIP being the revolution, it makes me ponder if you are hinting towards it being more effective than aztreonam in gram negative lung bacterial infections? So is this headed towards a SOC preventative and reactive treatment for antibiotic resistant strains of bacteria that are causing pneumonia in hospital patients? My limited time researching, haven’t had a day off yet this week has pointed towards some research papers exploring the idea of Aviptadil in treatment of cystic fibrosis patients who are highly susceptible to bacterial lung infections. If this is the case, is VIP going to revolutionize not only respiratory illness, but also the world of bacterial infections in replacing antibiotics? Going on a limb here. Just wanted to know if this was headed into the direction that you and your team have already covered?
NeuroRx Facebook posted this article about an hour ago
https://www.bioworld.com/articles/496885-five-nmes-approved-in-july-covid-19-data-is-17?fbclid=IwAR2aBJqFErAViIEonxGiL61Aa16kINvm8AYidrhHBGKczhq8bW51mUgydZ4
Feel better now?
What are you rambling on about? It’s a matter of just getting free press. 90% of the dumb things the president says is on purpose just to get free publicity and stay relevant. I’m over here trying to give everyone ideas how to increase exposure to the stock and it’s turning political. I haven’t been on Facebook in a month because of that nightmare. Ffs. Get over it. We are on the same team rooting for the same stock to go up.
Just another thought for giving this stock some life.
Reach out to Andrew Cuomo and advocate for it to be brought to NY hospitals for compassionate care use.
Reach out to Chris Cuomo and ask why the president is pushing plasma and HCQ when clearly there is a drug with 90% success rate, put that little bug in there ear, give them a vector to build a story on. Not that I want this drug politicized. But if you want national coverage. Gotta give the right people the right ideas.
What ever you say pal..
Andrew Cuomo = Chris Cuomos brother.
Chris Cuomo = CNN’s prime time news caster. You want the most impact? Go to the source that has direct connection to CNN’s prime time hour. If we get Andrew on board, Chris falls in line and they have a major news story to push that day.